Diabetes

An innovative mix of readily available natural products shapes up as a long-term alternative to the likes of Ozempic for managing obesity, diabetes, liver health and inflammation – without the injections, cost or side effects associated with GLP-1 drugs.

A naturally occurring fat molecule reduced heart inflammation and scarring caused by diabetes, thereby improving cardiac function, according to new research. The findings open the door to developing a new treatment for diabetes-induced heart disease.

If you've never heard of fox nuts, you'd be forgiven for assuming that they don't seem particularly palatable. But they're actually starchy seeds harvested from an aquatic lily that boast vast health benefits. And no foxes are harmed in the process.

Game-changing GLP-1 agonist drugs are a step closer to being available in oral pill form, with AstraZeneca revealing "encouraging data" from the Phase I safety and tolerability trial of its once-daily obesity and diabetes drug AZD5004.

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. It could be an effective alternative to regular injections of medication directly into the eye.

A new continuous glucose monitor (CGM) that is not only non-invasive but that predicts blood sugar levels from ECG data promises to shake up diabetes management. The device is being showcased at the 2024 Taiwan Innotech Expo.

An insulin that switches itself on and off in response to blood glucose levels has proven successful in lowering the risk of dangerously low glucose levels, or hypos, in animals. The drug holds great promise for the tens of millions of diabetics worldwide.

86% of type 2 diabetics treated with a new procedure no longer needed insulin throughout the two-year-long study they participated in. That procedure could be a real game changer for nearly half a billion people living with the condition worldwide.

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar levels, according to new research.

A patient with type 1 diabetes has been functionally cured of the disease, requiring no insulin doses for over a year. The treatment involves growing and transplanting new insulin-producing cells from the patient’s own stem cells.

Implanting a pouch of pancreas cells under the skin of type 1 diabetics has enabled them to live without insulin injections for years according to the results of a clinical trial. It’s a big step towards a functional cure for the disease.

Clinical trials of a new, once-a-week insulin have shown that it controls blood sugar as well as daily injections of an existing long-acting insulin in type 1 and type 2 diabetics. This means that some diabetics may soon not need to inject themselves as often.